The samples included in the discovery phase of the present GWAS were included in the in silico replication stage of the Siddiq (2012) GWAS meta-analysis of ER-neg breast cancer # SNPs were included in the analysis if they were registered in the Catalog of Published Genome-Wide Association Studies compiled by the National Human Genome Research Institute. In addition, we used a restriction criteria of p value lower than 5x10 -8 The samples included in the discovery phase of the present GWAS were included in the in silico replication stage of the Siddiq (2012) GWAS meta-analysis of ER-neg breast cancer # SNPs were included in the analysis if they were registered in the Catalog of Published Genome-Wide Association Studies compiled by the National Human Genome Research Institute. In addition, we used a restriction criteria of p value lower than 5x10 -8 . Figure 1 : Correlation (r 2 ) between previously reported risk variants at 6q25 (bold red), rs140068132/rs147157845 (bold black) and other SNPs in the region with P values <0.05 in the sequence data breast cancer case/control analysis among the U.S. Latinas from the Multiethnic Cohort (black). r2 categories are <0.2 (lighter blue), 0.2-0.4 (turquoise), and >0.4 (darker blue).
Figure 2: Scatterplot of tested allele frequencies previously published (X axis) and in Latinas (Y axis) Figure 3 : UCSC genome browser with ENCODE transcription factor binding sites track (the location of rs140068132 and rs147157845 is included within the figure) | rs140068132 | rs147157845 Figure 4 : EMSA demonstrating control reaction lanes 1-3 and differential binding of A/G SNP rs140068132 to nuclear protein derived from MCF-7 cells, A allele lanes 4-6, G allele lanes 7-9. Shift is demonstrated in lanes 5 and 8, respectively, with greater protein binding in lane 5 with A allele as compared to lane 8 with G allele. This shift is specific to the sequence including the SNP as a 500 fold molar excess of unbiotinylated primers of identical sequence quenches the reactions as demonstrated in lanes 6 and 9.
Lane 1 2 3 4 5 6 7 8 9 Unbiotinylated Primer --+ --+ --+ Nuclear Protein Extract -+ + -+ + -+ + Biotinylated Primer + + + + + + + + + Figure 5 : Scatter plot of 1 st and 2 nd principal components among U.S. Latinas included in the discovery phase of the breast cancer GWAS (N=4710) and HapMap ancestral samples
